Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• Tarsus Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -7.0 M, a 72.27% decrease year-over-year.
• Tarsus Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -65.0 M, a 50.59% decrease year-over-year.
• Tarsus Pharmaceuticals Inc. annual net income for 2025 was -66.4 M, a 42.52% decrease from 2024.
• Tarsus Pharmaceuticals Inc. annual net income for 2024 was -115.6 M, a 14.97% decrease from 2023.
• Tarsus Pharmaceuticals Inc. annual net income for 2023 was -135.9 M, a 118.86% increase from 2022.
• Tarsus Pharmaceuticals Inc. annual net income for 2022 was -62.1 M.